The nucleotide analog remdesivir, a promising antiviral drug against coronavirus. 3D render via iStock / selvanegra

Experimental drug remdesivir administered to first Czech coronavirus patient

The General Teaching Hospital in Prague has received the antiviral drug and started administering it to a patient seriously ill with COVID-19 today

Prague, March 24 (CTK) – The General Teaching Hospital in Prague received the remdesivir novel antiviral drug and it started administering it to a patient seriously ill with COVID-19 today, Health Minister Adam Vojtech (for ANO) has told CTK.

The man is attached to a special device blowing oxygen into his blood.

Advertise with

The hospital received the permit to use the experimental drug from the U.S. firm Gilead.

On Sunday, Gilead said that due to an excessive demand in recent days, it had stopped issuing permits for experimental treatment. Pregnant women and children under 18 are to be the only exception.

Remdesivir was developed by Gilead Sciences as a treatment for the Ebola virus disease. After the epidemic was halted, the tests of the drug were discontinued.

Advertise with

The World Health Organisation (WHO) has described remdesivir as the most promising candidate in the fight against the novel coronavirus. It was efficient when administered against the SARS and MERS diseases, caused by a similar type of coronavirus.

Also read:  Prague nurse infected with COVID-19 dies

This morning, the Czech Republic had 1,289 confirmed coronavirus cases. There was one fatality and seven people have recovered.

Advertise with

Leave a Reply

Related posts

Sign up for our Newsletter

Enter your email to receive a weekly news update from directly to your inbox! We will never share your email or send you spam.

Close Menu